A Case of Erythema Multiforme Major Developed after Sequential Use of Two Immune Checkpoint Inhibitors, Nivolumab and Ipilimumab, for Advanced Melanoma: Possible Implication of Synergistic and/or Complementary Immunomodulatory Effects.
| Image |  |
|---|---|
| Description | scientific article published on 18 January 2018 |
| Author/s |
author: Minoru Hasegawa Noritaka Oyama |
| Publication date | January 18, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |